NE
Neuphoria Therapeutics Inc.
NEUP · NASDAQ
$3.71 -1.33% (-$0.05)
1M -6.08%
Market Cap $20.1M
P/E Ratio -
Div. Yield -
ROE 77.03%
Bulios Fair Price
$5.55
49.6% upside
Trenutna cena
$3.71
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NEUP trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 0.82x
P/S 17.08x
EV/FFO N/A
Growth
100 /100
Growing Book val. growth 1,088.56%
Rev. growth N/A
FCF growth N/A
Profitability
17 /100
Weak Net margin 1,578.40%
Op. margin 1,187.73%
FCF margin 1,052,120.00%
Quality
0 /100
Poor ROE 77.03%
ROA 64.55%
Asset turnover 0.04x
Debt
100 /100
Low Current ratio 27.85x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
37 /100
Moderate EPS volatility 691.22%
Profitable years 0
Beta 0.75x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NEUP
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Spyridon Papapetropoulos
Employees
8
Headquarters
Burlington